Young Mi Kim - Search Results

Year	Number of Results
1998	1
2001	1
2002	16
2003	13
2004	12
2005	9
2006	12
2007	16
2008	19
2009	25
2010	22
2011	32
2012	35
2013	26
2014	28
2015	40
2016	37
2017	38
2018	32
2019	33
2020	31
2021	29
2022	19
2023	24
2024	7

1

Disorders Associated With Diverse, Recurrent Deletions and Duplications at 1q21.1.

Pang H, Yu X, Kim YM, Wang X, Jinkins JK, Yin J, Li S, Gu H. Pang H, et al. Among authors: kim ym. Front Genet. 2020 Jun 23;11:577. doi: 10.3389/fgene.2020.00577. eCollection 2020. Front Genet. 2020. PMID: 32655619 Free PMC article.

2

Therapeutic application of GPR119 ligands in metabolic disorders.

Yang JW, Kim HS, Choi YW, Kim YM, Kang KW. Yang JW, et al. Among authors: kim ym. Diabetes Obes Metab. 2018 Feb;20(2):257-269. doi: 10.1111/dom.13062. Epub 2017 Aug 22. Diabetes Obes Metab. 2018. PMID: 28722242 Review.

3

dRAGging amino acid-mTORC1 signaling by SH3BP4.

Kim YM, Kim DH. Kim YM, et al. Mol Cells. 2013 Jan;35(1):1-6. doi: 10.1007/s10059-013-2249-1. Epub 2012 Dec 26. Mol Cells. 2013. PMID: 23274731 Free PMC article. Review.

4

Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin.

Kim HY, Otgontenger U, Kim JW, Lee YJ, Kim SB, Lim SC, Kim YM, Kang KW. Kim HY, et al. Among authors: kim ym. Arch Pharm Res. 2023 Mar;46(3):149-159. doi: 10.1007/s12272-023-01438-1. Epub 2023 Mar 10. Arch Pharm Res. 2023. PMID: 36894745 Free PMC article.

5

Photonic-Plasmonic Nanostructures for Solar Energy Utilization and Emerging Biosensors.

Tran VT, Nguyen HQ, Kim YM, Ok G, Lee J. Tran VT, et al. Among authors: kim ym. Nanomaterials (Basel). 2020 Nov 12;10(11):2248. doi: 10.3390/nano10112248. Nanomaterials (Basel). 2020. PMID: 33198391 Free PMC article. Review.

6

Controversial roles of cold‑inducible RNA‑binding protein in human cancer (Review).

Kim YM, Hong S. Kim YM, et al. Int J Oncol. 2021 Nov;59(5):91. doi: 10.3892/ijo.2021.5271. Epub 2021 Sep 24. Int J Oncol. 2021. PMID: 34558638 Review.

7

The role of sphingolipids in drug metabolism and transport.

Kim YM, Park TS, Kim SG. Kim YM, et al. Expert Opin Drug Metab Toxicol. 2013 Mar;9(3):319-31. doi: 10.1517/17425255.2013.748749. Epub 2013 Jan 7. Expert Opin Drug Metab Toxicol. 2013. PMID: 23289866 Review.

8

Discovery of Hippo signaling as a regulator of CSPG4 expression and as a therapeutic target for Clostridioides difficile disease.

Larabee JL, Doyle DA, Ahmed UKB, Shadid TM, Sharp RR, Jones KL, Kim YM, Li S, Ballard JD. Larabee JL, et al. Among authors: kim ym. PLoS Pathog. 2023 Mar 27;19(3):e1011272. doi: 10.1371/journal.ppat.1011272. eCollection 2023 Mar. PLoS Pathog. 2023. PMID: 36972308 Free PMC article.

9

Pellino 3 promotes the colitis-associated colorectal cancer through suppression of IRF4-mediated negative regulation of TLR4 signalling.

Kim YM, Kim HY, Ha Thi HT, Kim J, Lee YJ, Kim SJ, Hong S. Kim YM, et al. Mol Oncol. 2023 Nov;17(11):2380-2395. doi: 10.1002/1878-0261.13475. Epub 2023 Jun 27. Mol Oncol. 2023. PMID: 37341064 Free PMC article.

10

Drug-induced hyperbilirubinemia and the clinical influencing factors.

Ah YM, Kim YM, Kim MJ, Choi YH, Park KH, Son IJ, Kim SG. Ah YM, et al. Among authors: kim ym. Drug Metab Rev. 2008;40(4):511-37. doi: 10.1080/03602530802341133. Drug Metab Rev. 2008. PMID: 18821100 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

492 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

492 results

Results by year